Siddharth Kaul
Director/Board Member at IMMUNOCORE HOLDINGS PLC
Net worth: - $ as of 2024-04-29
Profile
Siddharth Kaul is currently serving as the Director at Helsinn Healthcare SA since 2022.
He is also an Independent Non-Executive Director at Immunocore Holdings Plc since 2022.
Additionally, Mr. Kaul holds the position of Non-Executive Director at Immunocore Ltd.
Mr. Kaul previously worked as the Chief Financial Officer-Pharma Europe at Novartis AG in 2021.
He holds an MBA from Indiana University and an undergraduate degree from West Virginia University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
nan% | 2024-01-01 | 0 ( nan% ) | - $ | 2024-04-29 |
Siddharth Kaul active positions
Companies | Position | Start |
---|---|---|
IMMUNOCORE HOLDINGS PLC | Director/Board Member | 2022-06-07 |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Director/Board Member | 2022-01-14 |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Director/Board Member | - |
Former positions of Siddharth Kaul
Companies | Position | End |
---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 2021-03-31 |
Training of Siddharth Kaul
West Virginia University | Undergraduate Degree |
Indiana University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
IMMUNOCORE HOLDINGS PLC | Health Technology |
NOVARTIS AG | Health Technology |
Private companies | 2 |
---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
- Stock Market
- Insiders
- Siddharth Kaul